CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
Canada - TSX:CHR - CA17040T8885 - Common Stock
19.73 CAD
-0.08 (-0.4%)
Overall CHR gets a fundamental rating of 4 out of 10. We evaluated CHR against 9 industry peers in the Passenger Airlines industry. CHR has only an average score on both its financial health and profitability. CHR is cheap, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
In the past year CHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
CHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CHR's Return On Assets of -1.91% is in line compared to the rest of the industry. CHR outperforms 55.56% of its industry peers.
CHR has a Return On Equity (-4.82%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 6.54%, CHR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHR is in line with the industry average of 5.58%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.91% | ||
| ROE | -4.82% | ||
| ROIC | 6.54% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
CHR has a Operating Margin of 6.87%. This is in the better half of the industry: CHR outperforms 66.67% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
CHR has a Gross Margin of 65.48%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.87% | ||
| PM (TTM) | N/A | ||
| GM | 65.48% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CHR has an improved debt to assets ratio.
2.2 Solvency
CHR has an Altman-Z score of 0.86. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CHR (0.86) is worse than 66.67% of its industry peers.
CHR has a debt to FCF ratio of 7.89. This is a slightly negative value and a sign of low solvency as CHR would need 7.89 years to pay back of all of its debts.
CHR has a Debt to FCF ratio of 7.89. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
CHR has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR is somewhat dependend on debt financing.
CHR has a better Debt to Equity ratio (0.54) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 7.89 | ||
| Altman-Z | 0.86 |
ROIC/WACC0.8
WACC8.2%
2.3 Liquidity
CHR has a Current Ratio of 1.14. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.14, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 0.61 indicates that CHR may have some problems paying its short term obligations.
CHR has a Quick ratio of 0.61. This is comparable to the rest of the industry: CHR outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
CHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -19.03% yearly.
CHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.36%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
3.2 Future
Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 1.21% on average per year.
The Revenue is expected to decrease by -5.14% on average over the next years.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.77, the valuation of CHR can be described as very reasonable.
CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. CHR is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 10.24 indicates a reasonable valuation of CHR.
88.89% of the companies in the same industry are more expensive than CHR, based on the Price/Forward Earnings ratio.
CHR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.71.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.77 | ||
| Fwd PE | 10.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHR is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
77.78% of the companies in the same industry are more expensive than CHR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.37 | ||
| EV/EBITDA | 3.92 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%
5. Dividend
5.1 Amount
CHR has a Yearly Dividend Yield of 1.63%. Purely for dividend investing, there may be better candidates out there.
CHR's Dividend Yield is comparable with the industry average which is at 2.69.
Compared to the average S&P500 Dividend Yield of 2.38, CHR is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
5.2 History
On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of CHR are negative and hence is the payout ratio. CHR will probably not be able to sustain this dividend level.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
TSX:CHR (9/16/2025, 7:00:00 PM)
19.73
-0.08 (-0.4%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap504.89M
Analysts78
Price Target28.6 (44.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.63% |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)-0.23%
PT rev (3m)1.31%
EPS NQ rev (1m)-1.03%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)-4.29%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-3.2%
Revenue NY rev (1m)-2.42%
Revenue NY rev (3m)-2.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.77 | ||
| Fwd PE | 10.24 | ||
| P/S | 0.37 | ||
| P/FCF | 10.37 | ||
| P/OCF | 5.97 | ||
| P/B | 0.94 | ||
| P/tB | 0.96 | ||
| EV/EBITDA | 3.92 |
EPS(TTM)2.25
EY11.4%
EPS(NY)1.93
Fwd EY9.77%
FCF(TTM)1.9
FCFY9.64%
OCF(TTM)3.3
OCFY16.75%
SpS53.45
BVpS20.99
TBVpS20.65
PEG (NY)0.16
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.91% | ||
| ROE | -4.82% | ||
| ROCE | 8.82% | ||
| ROIC | 6.54% | ||
| ROICexc | 6.9% | ||
| ROICexgc | 6.96% | ||
| OM | 6.87% | ||
| PM (TTM) | N/A | ||
| GM | 65.48% | ||
| FCFM | 3.56% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.54 | ||
| Debt/FCF | 7.89 | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 30.21% | ||
| Cap/Sales | 2.62% | ||
| Interest Coverage | 2.06 | ||
| Cash Conversion | 39.75% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.14 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 0.86 |
F-Score5
WACC8.2%
ROIC/WACC0.8
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%